Table of Contents

company-logo

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Day One Biopharmaceuticals Dividend Announcement

• Day One Biopharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Day One Biopharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Day One Biopharmaceuticals Dividend History

Day One Biopharmaceuticals Dividend Yield

Day One Biopharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Day One Biopharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Day One Biopharmaceuticals Financial Ratios

P/E ratio-18.34
PEG ratio0.16
P/B ratio2.78
ROE-22.40%
Payout ratio0.00%
Current ratio14.62
Quick ratio14.55
Cash Ratio10.64

Day One Biopharmaceuticals Dividend FAQ

Does Day One Biopharmaceuticals stock pay dividends?
Day One Biopharmaceuticals does not currently pay dividends to its shareholders.
Has Day One Biopharmaceuticals ever paid a dividend?
No, Day One Biopharmaceuticals has no a history of paying dividends to its shareholders. Day One Biopharmaceuticals is not known for its dividend payments.
Why doesn't Day One Biopharmaceuticals pay dividends?
There are several potential reasons why Day One Biopharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Day One Biopharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Day One Biopharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Day One Biopharmaceuticals a dividend aristocrat?
Day One Biopharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Day One Biopharmaceuticals a dividend king?
Day One Biopharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Day One Biopharmaceuticals a dividend stock?
No, Day One Biopharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Day One Biopharmaceuticals stocks?
To buy Day One Biopharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Day One Biopharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.